Close
0
You have no items in your order cart.
Search
Filters

Vaccines

View as Grid List
Sort by
Display per page

ErySeng Parvo - 50ml

132924
For the active immunisation of female pigs for the protection of progeny against transplacental infection caused by porcine parvovirus. For the active immunisation of male and female pigs to reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotype 1 and serotype 2. Onset of immunity: Porcine parvovirus: from the beginning of the gestation period. E.rhusiopathiae: three weeks after completion of the basic vaccination scheme. Duration of immunity: Porcine parvovirus: vaccination provides foetal protection for the duration of gestation. Revaccination should be performed prior to each gestation, refer to section “Dosage for each species, route(s) and method of administration”. E. rhusiopathiae: vaccination protects against swine erysipelas until the time of the recommended revaccination (approximately six months after the basic vaccination scheme)

Eurican Dhppi - 1ml x10

124090
A combined live freeze-dried vaccine against canine distemper, infectious canine hepatitis, canine parvovirus and canine parainfluenza virus type 2. Each 1-ml dose of vaccine contains attenuated canine distemper virus, at least 104.0 CCID50, attenuated canine adenovirus (CAV2), at least 102.5 CCID50, attenuated canine parvovirus, at least 104.9 CCID50, attenuated canine parainfluenza type 2 virus, at least 104.7 CCID50 Uses Dogs and puppies from 8 weeks of age: Active immunization against distemper to reduce mortality and clinical signs; against infectious canine hepatitis to prevent clinical signs; against parvovirus to prevent clinical signs and reduce mortality and viral excretion; and against parainfluenza type 2 infections to reduce clinical signs and viral excretion. Onset of immunity: 2 weeks after completion of the primary vaccination course. Duration of immunity: 1 year. Dosage and administration Reconstitute the vaccine with Eurican L using a clean sterile syringe. Use the vaccine immediately after reconstitution of the freeze-dried pellet. Apply usual aseptic procedures. Use sterile and/or disinfectant-free equipment for injection purposes. Administer by subcutaneous injection. The following vaccination schedule is recommended: Primary vaccination: 1st injection: from 8th week of age. 2nd injection: 3 to 5 weeks later, from 12th week of age. Revaccination: Booster injections should be given annually thereafter.

Eurican Herpes - 1ml

110061
Active immunisation of bitches to prevent mortality, clinical signs and lesions in puppies resulting from canine herpes virus infections acquired in the first few days of life.

Eurican L - 1ml x10

124130
Active immunisation against Leptospira canicola and Leptospira icterohaemorrhagiae to prevent mortality and to reduce clinical symptoms of Leptospira infections caused by these agents. For dogs and puppies from 8 weeks of age. VPA 10857/055/001.

Eurican L Multi - 1ml x10

141334
Indications for use Active immunisation of dogs to: -prevent mortality, clinical signs, infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae -prevent mortality* and clinical signs, reduce infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira interrogans serogroup Canicola serovar Canicola. -prevent mortality*, and reduce clinical signs, infection, bacterial excretion renal carriage and renal lesions caused by Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa. - prevent mortality, clinical signs, renal infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni.** Onset of immunity: 2 weeks after the second injection of the primary vaccination course for all strains Duration of immunity: at least one year after the second injection of the primary vaccination course for all strains * For Leptospira Canicola and Grippotyphosa, no mortality occurred during challenge experiment for duration of immunity. ** For Leptospira Copenhageni the duration of immunity was not establishedIndications for use Active immunisation of dogs to: -prevent mortality, clinical signs, infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira interrogans serogroup Icterohaemorrhagiae serovar Icterohaemorrhagiae -prevent mortality* and clinical signs, reduce infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira interrogans serogroup Canicola serovar Canicola. -prevent mortality*, and reduce clinical signs, infection, bacterial excretion renal carriage and renal lesions caused by Leptospira kirschneri serogroup Grippotyphosa serovar Grippotyphosa. - prevent mortality, clinical signs, renal infection, bacterial excretion, renal carriage and renal lesions caused by Leptospira interrogans serogroup Icterohaemorrhagiae serovar Copenhageni.** Onset of immunity: 2 weeks after the second injection of the primary vaccination course for all strains Duration of immunity: at least one year after the second injection of the primary vaccination course for all strains * For Leptospira Canicola and Grippotyphosa, no mortality occurred during challenge experiment for duration of immunity. ** For Leptospira Copenhageni the duration of immunity was not established

Eurican/Purevax Syringe

148164
For use with Eurican & Purevax vaccines

Evalon - 1000 Dose

142004
For active immunisation of chicks to reduce clinical signs, intestinal lesions and oocysts output of Coccidiosis caused by Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria necatrix and Eimeria tenella. Onset of immunity: 3 weeks post-vaccination. Duration of immunity: 60 weeks post-vaccination. One dose of vaccine from 1 day of age by coarse spray

Evalon - 5000 Dose

142014
For active immunisation of chicks to reduce clinical signs, intestinal lesions and oocysts output of Coccidiosis caused by Eimeria acervulina, Eimeria brunetti, Eimeria maxima, Eimeria necatrix and Eimeria tenella. Onset of immunity: 3 weeks post-vaccination. Duration of immunity: 60 weeks post-vaccination. One dose of vaccine from 1 day of age by coarse spray

Fevaxyn Pentofel IE/SE/FI - 1ml x10

114661
For active immunisation of healthy cats of 9 weeks of age or older against Feline panleukopenia, Feline leukaemia viruses and against respiratory disease caused by Feline rhinotracheitis virus, Feline caliciviris and Chlamydophila felis. Single subcutaneous dose. .

Footvax - 20ml

135074
For the active immunisation of sheep as an aid to the prevention of footrot and reduction of lesions of footrot caused by serotypes of D. nodosus. Dosage & Administration Dose: 1 ml Administration: Initial Course: • Two doses, 6 weeks apart by subcutaneous injection. • The site for injection is on the side of the neck 2 - 3 inches behind the ear. • Thoroughly shake the vaccine before use. • As the vaccine contains an oil adjuvant it is rather viscous. It will aid administration in cold weather if the vaccine is gently warmed by immersion in warm water (not hot) for 3 - 4 minutes before use. • Syringes and needles should be sterilised before use and the injection made through an area of clean, dry skin, taking strict precautions against contamination in order to reduce the possibility of abscess formation. Vaccination programmes • These should be tailored to meet individual flock requirements which will vary from season to season according to the actual or likely incidence of footrot. • Wherever possible ‘whole flock’ vaccination programmes should be adopted. By this means disease incidence in the flock will decline and subsequent disease risk from the environment will be greatly reduced. Prevention programme • Commence vaccination with a single dose of vaccine. • Further doses of vaccine will be required according to the flock disease status and/or the climatic conditions. • If, after 4 - 6 weeks significant levels of disease remain in the flock or climatic conditions conducive to footrot persist, administer a further dose. Otherwise delay this dose until conditions favour re-emergence of the disease. • Subsequent doses should also be administered according to prevailing conditions. Thus, with severe and constant disease challenge, revaccination may be necessary at 4 - 5 monthly intervals; conversely under favourable conditions revaccination may be delayed until the incidence of disease challenge increases or climatic conditions worsen. • It should be noted that these adverse conditions tend to occur in the UK between March and May and between October and December thus, vaccination should normally be completed shortly before these periods if problems are anticipated. Treatment programme • A single dose of vaccine should be given to the flock immediately the disease becomes apparent. • For maximum effect, treatment with Footvax should be combined with the use of a footbath and antibiotic treatment. Revaccination: • should be as stated in the prevention programme, which should then be continued on the farm as the key element of the overall flock foot care programme.

Footvax - 250ml

152274
For the active immunisation of sheep as an aid to the prevention of footrot and reduction of lesions of footrot caused by serotypes of D. nodosus. Dosage & Administration Dose: 1 ml Administration: Initial Course: • Two doses, 6 weeks apart by subcutaneous injection. • The site for injection is on the side of the neck 2 - 3 inches behind the ear. • Thoroughly shake the vaccine before use. • As the vaccine contains an oil adjuvant it is rather viscous. It will aid administration in cold weather if the vaccine is gently warmed by immersion in warm water (not hot) for 3 - 4 minutes before use. • Syringes and needles should be sterilised before use and the injection made through an area of clean, dry skin, taking strict precautions against contamination in order to reduce the possibility of abscess formation. Vaccination programmes • These should be tailored to meet individual flock requirements which will vary from season to season according to the actual or likely incidence of footrot. • Wherever possible ‘whole flock’ vaccination programmes should be adopted. By this means disease incidence in the flock will decline and subsequent disease risk from the environment will be greatly reduced. Prevention programme • Commence vaccination with a single dose of vaccine. • Further doses of vaccine will be required according to the flock disease status and/or the climatic conditions. • If, after 4 - 6 weeks significant levels of disease remain in the flock or climatic conditions conducive to footrot persist, administer a further dose. Otherwise delay this dose until conditions favour re-emergence of the disease. • Subsequent doses should also be administered according to prevailing conditions. Thus, with severe and constant disease challenge, revaccination may be necessary at 4 - 5 monthly intervals; conversely under favourable conditions revaccination may be delayed until the incidence of disease challenge increases or climatic conditions worsen. • It should be noted that these adverse conditions tend to occur in the UK between March and May and between October and December thus, vaccination should normally be completed shortly before these periods if problems are anticipated. Treatment programme • A single dose of vaccine should be given to the flock immediately the disease becomes apparent. • For maximum effect, treatment with Footvax should be combined with the use of a footbath and antibiotic treatment. Revaccination: • should be as stated in the prevention programme, which should then be continued on the farm as the key element of the overall flock foot care programme.

Footvax - 50ml

109920
For the active immunisation of sheep as an aid to the prevention of footrot and reduction of lesions of footrot caused by serotypes of D. nodosus. Dosage & Administration Dose: 1 ml Administration: Initial Course: • Two doses, 6 weeks apart by subcutaneous injection. • The site for injection is on the side of the neck 2 - 3 inches behind the ear. • Thoroughly shake the vaccine before use. • As the vaccine contains an oil adjuvant it is rather viscous. It will aid administration in cold weather if the vaccine is gently warmed by immersion in warm water (not hot) for 3 - 4 minutes before use. • Syringes and needles should be sterilised before use and the injection made through an area of clean, dry skin, taking strict precautions against contamination in order to reduce the possibility of abscess formation. Vaccination programmes • These should be tailored to meet individual flock requirements which will vary from season to season according to the actual or likely incidence of footrot. • Wherever possible ‘whole flock’ vaccination programmes should be adopted. By this means disease incidence in the flock will decline and subsequent disease risk from the environment will be greatly reduced. Prevention programme • Commence vaccination with a single dose of vaccine. • Further doses of vaccine will be required according to the flock disease status and/or the climatic conditions. • If, after 4 - 6 weeks significant levels of disease remain in the flock or climatic conditions conducive to footrot persist, administer a further dose. Otherwise delay this dose until conditions favour re-emergence of the disease. • Subsequent doses should also be administered according to prevailing conditions. Thus, with severe and constant disease challenge, revaccination may be necessary at 4 - 5 monthly intervals; conversely under favourable conditions revaccination may be delayed until the incidence of disease challenge increases or climatic conditions worsen. • It should be noted that these adverse conditions tend to occur in the UK between March and May and between October and December thus, vaccination should normally be completed shortly before these periods if problems are anticipated. Treatment programme • A single dose of vaccine should be given to the flock immediately the disease becomes apparent. • For maximum effect, treatment with Footvax should be combined with the use of a footbath and antibiotic treatment. Revaccination: • should be as stated in the prevention programme, which should then be continued on the farm as the key element of the overall flock foot care programme.